FDA Solves One IT Challenge, But More Tech Hurdles Await – And Congress Is Watching
This article was originally published in The Pink Sheet Daily
Congressional scrutiny of FDA’s overall document management challenges unlikely to let up despite adverse event success story.
You may also be interested in...
House Energy and Commerce committee says it’s committed to a bill to accelerate U.S. biomedical innovation before the next FDA user fee cycle, but the wide scope of needs and stakeholders may make crafting legislation challenging – never mind getting it passed.
Strategic plan says CDER will streamline its processes and may find activities that could be “cut altogether.”
New CIO will help develop new policy to protect sensitive information at FDA, while also balancing individual privacy and security.